Market Insights Snapshot
In the Capsules category, Stigma Grow maintained a solid performance across multiple states. In Alberta, they consistently held the number 1 rank from August to November 2023, demonstrating their dominance in the market. The brand showed similar stability in British Columbia and Ontario, holding the 6th and 7th ranks respectively throughout the same period. However, in Saskatchewan, there was a noticeable fluctuation in their ranking, dropping from 5th to 10th place over the four months.
When it comes to Concentrates, the brand's performance varied significantly across states. In Alberta, Stigma Grow managed to improve its ranking from 16th to 15th between August and November 2023. In British Columbia, the brand showed a positive trend, moving from the 25th rank in August to 19th in November 2023. However, in Ontario, the brand's performance was less impressive, with rankings outside the top 20. In Saskatchewan, the brand did not make it to the top 20 at all, indicating a need for improvement in their Concentrates category in this state.
In the Capsules category within Alberta, Stigma Grow has consistently maintained the top rank from August to November 2023, indicating a strong market presence and consumer preference. However, it's worth noting the upward trajectory of its competitors. Glacial Gold, despite not ranking in the top 20 in August, made a significant leap to 13th place in September, and by November, it had climbed to the 3rd spot. This rapid rise suggests a growing consumer interest and potential threat to Stigma Grow's dominance. Meanwhile, Ovis has consistently held the 2nd rank, indicating a steady demand. While Stigma Grow remains the market leader, these trends suggest a dynamic competitive landscape with emerging players gaining momentum.
In November 2023, Stigma Grow's top-performing product was the Indica RSO Capsules 25-Pack (250mg) from the Capsules category, maintaining its first-place ranking and achieving significant sales of 9269 units. The second best-selling product was Phoenix Tears RSO (1g) from the Concentrates category, also retaining its rank from previous months. The CBD Softgels 15-Pack (750mg CBD), another product in the Capsules category, held onto its third-place position. Notably, the RSO Capsules 30-Pack (75mg) moved up from the fifth to the fourth rank, indicating a growing consumer preference. However, the Phoenix Tears Honey Oil (1g) dropped to the fifth position from its previous fourth rank in October.